Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Procept Biorobotics Corp
(NQ:
PRCT
)
52.98
+0.93 (+1.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
875,721
Open
51.82
Bid (Size)
52.90 (1)
Ask (Size)
58.00 (1)
Prev. Close
52.05
Today's Range
51.53 - 54.00
52wk Range
24.83 - 54.79
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
April 29, 2024
Japanese post market survey supports safety and efficacy of Aquablation therapy
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
April 23, 2024
Presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two FDA trials
From
PROCEPT BioRobotics
Via
GlobeNewswire
Performance
YTD
+27.85%
+27.85%
1 Month
+12.72%
+12.72%
3 Month
+11.84%
+11.84%
6 Month
+97.76%
+97.76%
1 Year
+69.32%
+69.32%
More News
Read More
PROCEPT BioRobotics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
PROCEPT BioRobotics's Earnings: A Preview
February 26, 2024
Via
Benzinga
Demystifying PROCEPT BioRobotics: Insights From 4 Analyst Reviews
January 09, 2024
Via
Benzinga
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
April 04, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
April 02, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Truist Securities Maintains Buy Rating for PROCEPT BioRobotics: Here's What You Need To Know
February 28, 2024
Via
Benzinga
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
February 27, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
February 12, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Procept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest'
January 09, 2024
Via
Benzinga
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
January 08, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Stock Scores Rising Relative Strength
December 05, 2023
Via
Investor's Business Daily
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
November 13, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
November 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
The 7 Best Tech Stocks To Buy Now: October 2023
October 22, 2023
Via
InvestorPlace
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
October 16, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
October 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
September 20, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
September 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 22, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 17, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
August 16, 2023
From
PROCEPT BioRobotics; NorthShore University HealthSystem
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
August 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.